About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Current Search
Report Type
Organization
Disposition
Year
Month
Found 6645 record(s)
Req # A-2020-000241
Adverse Reaction Reports (AERs) for ZENHALE. Report numbers: 000546550, E2B_00037157, E2B_00282538, E2B_00356618, E2B_01322347, E2B_01490363, E2B_01907640.Organization: Health Canada
March 2021
Req # A-2020-000250
Adverse Reaction Reports (AERs) for FUROSEMIDE. Report numbers: E2B_02714932, E2B_02698395, E2B_02669273, E2B_02760580, E2B_02736554, E2B_02673074, E2B_02769575, E2B_02643642, E2B_02721613, E2B_02758498, E2B_02115509, E2B_02745409, E2B_02703856.Organization: Health Canada
March 2021
Req # A-2020-000251
Adverse Reaction Reports (AERs) for HYDROXYCHLOROQUINE SULFATE. Report numbers: E2B_02796933, E2B_02753830, E2B_02794433.Organization: Health Canada
March 2021
Req # A-2020-000326
Adverse Reaction Reports (AERs) for Mezavant. Report numbers: E2B_02825035, E2B_02882429, E2B_02907794, E2B_02913170, E2B_02913375, E2B_02973212, E2B_02959658, E2B_02955630, E2B_02955280, E2B_02944188, E2B_02933965, E2B_02931008, E2B_02925932.Organization: Health Canada
March 2021
Req # A-2020-000345
Adverse Reaction Reports (AERs) for DOCETAXEL. Report numbers: 730196, 730327, E2B_02732623, E2B_02753818, E2B_02762244, E2B_02762344, E2B_02800999, E2B_02802349, E2B_02803762, E2B_02803765, E2B_02803797.Organization: Health Canada
March 2021
Req # A-2020-000347
Adverse Drug Reaction (ADR) for BISACODYL. Report number: 730804.Organization: Health Canada
March 2021
Req # A-2020-000364
Adverse Drug Reaction (ADR) for TERIFLUNOMIDE. Report number: E2B_02791526.Organization: Health Canada
March 2021
Req # A-2020-000406
Adverse Reaction Reports (AERs). Report numbers: 000911061, 000912202, 000912665, E2B_02987894.Organization: Health Canada
March 2021
Req # A-2020-000527
Adverse Reaction Reports (AERs) for FLUDARABINE PHOSPHATE. Report numbers: E2B_02951555, E2B_02951583, E2B_02955577, E2B_02955586, E2B_02955589, E2B_02955606, E2B_02955634, E2B_02955779, E2B_02955808, E2B_02955816, E2B_00056421, E2B_02959450.Organization: Health Canada
March 2021
Req # A-2020-000535
Adverse Reaction Reports (AERs) for IRBESARTAN. Report numbers: E2B_02857059, 733235.Organization: Health Canada
March 2021